We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
GE Aerospace
GE
$296B
| $46.2K | 0.02% |
124
| – | – |
2019 Q4
26 quarters
|
|
177
Barrick Mining
B
$62.8B
| $46.2K | 0.02% |
1,259
+4
| +0.3% | +$164 |
2025 Q2
4 quarters
|
|
178
iShares MSCI India Small-Cap ETF
SMIN
$659M
| $43.5K | 0.01% |
615
| – | – |
2024 Q3
7 quarters
|
|
179
Astera Labs
ALAB
$44.6B
| $43.5K | 0.01% |
90
| – | – |
2025 Q4
2 quarters
|
|
180
Schwab US Dividend Equity ETF
SCHD
$118B
| $42.7K | 0.01% |
1,345
-1,579
| -54% | -$50.1K |
2023 Q4
10 quarters
|
|
181
Starbucks
SBUX
$115B
| $41.4K | 0.01% |
405
| – | – |
2019 Q4
26 quarters
|
|
182
Knife River
KNF
$3.02B
| $41.3K | 0.01% |
494
| – | – |
2023 Q2
12 quarters
|
|
183
Adobe
ADBE
$103B
| $41K | 0.01% |
200
-1
| -0.5% | -$237 |
2019 Q4
26 quarters
|
|
184
Credo Technology Group
CRDO
$27.7B
| $40.8K | 0.01% |
150
| – | – |
2025 Q4
2 quarters
|
|
185
iShares Russell 2000 Growth ETF
IWO
$13.5B
| $40K | 0.01% |
101
| – | – |
2024 Q2
8 quarters
|
|
186
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
| $39.4K | 0.01% |
138
+6
| +5% | +$1.57K |
2022 Q3
15 quarters
|
|
187
Orthofix Medical
OFIX
$400M
| $39.4K | 0.01% |
4,310
| – | – |
2023 Q1
13 quarters
|
|
188
Visa
V
$766B
| $39.4K | 0.01% |
115
-42
| -27% | -$13.5K |
2019 Q4
26 quarters
|
|
189
Coinbase
COIN
$43.4B
| $39.3K | 0.01% |
269
+16
| +6% | +$2.89K |
2021 Q2
20 quarters
|
|
190
First Trust Natural Gas ETF
FCG
$699M
| $38.6K | 0.01% |
1,450
| – | – |
2021 Q4
18 quarters
|
|
191
Vertiv
VRT
$74.8B
| $38.5K | 0.01% |
115
| – | – |
2024 Q1
9 quarters
|
|
192
Vanguard Information Technology ETF
VGT
$147B
| $38.5K | 0.01% |
322
+2
| +0.6% | +$219 |
2024 Q1
9 quarters
|
|
193
First Trust Nasdaq Oil & Gas ETF
FTXN
$1.2B
| $38.4K | 0.01% |
1,150
| – | – |
2021 Q4
18 quarters
|
|
194
iShares US Real Estate ETF
IYR
$4.13B
| $38.4K | 0.01% |
375
| – | – |
2019 Q4
26 quarters
|
|
195
Yum! Brands
YUM
$40.9B
| $38.3K | 0.01% |
239
| – | – |
2019 Q4
26 quarters
|
|
196
Thermo Fisher Scientific
TMO
$249B
| $37.5K | 0.01% |
75
| – | – |
2019 Q4
26 quarters
|
|
197
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $37.3K | 0.01% |
464
| – | – |
2023 Q2
12 quarters
|
|
198
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $36.8K | 0.01% |
617
+1
| +0.2% | +$59 |
2019 Q4
26 quarters
|
|
199
CoStar Group
CSGP
$13.7B
| $36.7K | 0.01% |
1,296
| – | – |
2019 Q4
26 quarters
|
|
200
MDU Resources
MDU
$4.04B
| $35.6K | 0.01% |
1,679
| – | – |
2019 Q4
26 quarters
|
|
Similar funds
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.